FTD-GRN
Clinical trials for FTD-GRN explained in plain language.
Never miss a new study
Get alerted when new FTD-GRN trials appear
Sign up with your email to follow new studies for FTD-GRN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain-Delivered gene therapy tested to halt rare, Early-Onset dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is delivered directly into the brain during a single procedure, aiming to restore a missing protein and potentially s…
Matched conditions: FTD-GRN
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Brain injection trial aims to slow devastating dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy injection for adults with specific genetic forms of frontotemporal dementia (FTD). The treatment, called PBFT02, aims to deliver a working copy of a missing or faulty gene directly to the brain to potentially slow disease …
Matched conditions: FTD-GRN
Phase: PHASE1, PHASE2 • Sponsor: Passage Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC